Ductal carcinoma in situ: to treat or not to treat, that is the question

Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detection by population-based breast cancer screening programmes. Currently, all DCIS lesions are treated, and treatment comprises either mastectomy or breast-conserving surgery supplemented with radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales: van Seijen, Maartje, Lips, Esther H., Thompson, Alastair M., Nik-Zainal, Serena, Futreal, Andrew, Hwang, E. Shelley, Verschuur, Ellen, Lane, Joanna, Jonkers, Jos, Rea, Daniel W., Wesseling, Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697179/
https://www.ncbi.nlm.nih.gov/pubmed/31285590
http://dx.doi.org/10.1038/s41416-019-0478-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697179/
https://www.ncbi.nlm.nih.gov/pubmed/31285590
http://dx.doi.org/10.1038/s41416-019-0478-6

Ejemplares similares